Stockscreener 앱 받기
197.01
0.91%
1.77
시간 외 거래:
196.97
-0.04
-0.02%
전일 마감가:
$195.24
열려 있는:
$195
하루 거래량:
1.78M
Relative Volume:
0.76
시가총액:
$42.02B
수익:
$447.02M
순이익/손실:
$-1.18B
주가수익비율:
-31.87
EPS:
-6.1812
순현금흐름:
$-906.14M
1주 성능:
-3.43%
1개월 성능:
+1.35%
6개월 성능:
+103.35%
1년 성능:
+173.44%
1일 변동 폭
$191.74
$198.13
1주일 범위
$189.59
$206.69
52주 변동 폭
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-04 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-28 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
HRT Financial LP Takes Position in Insmed, Inc. $INSM - MarketBeat
Holocene Advisors LP Sells 9,616 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Holdings Boosted by Eventide Asset Management LLC - MarketBeat
Cubist Systematic Strategies LLC Takes $28.49 Million Position in Insmed, Inc. $INSM - MarketBeat
Brevan Howard Capital Management LP Takes Position in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Bellevue Group AG - MarketBeat
Alkeon Capital Management LLC Invests $50.32 Million in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Holdings Cut by Adage Capital Partners GP L.L.C. - MarketBeat
Annual Changes to the Nasdaq-100 Index® - GlobeNewswire Inc.
Maverick Capital Ltd. Purchases 379,008 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Federated Hermes Inc. - MarketBeat
Insmed (INSM): Assessing Valuation After a Strong Year of Share Price Gains - Yahoo Finance
Is It Too Late to Consider Insmed After a 179% Surge and DCF Upside? - Yahoo Finance
Is the Market Bullish or Bearish on Insmed Inc? - Sahm
TD Cowen Raises Price Target for Insmed (INSM) to $269 | INSM St - GuruFocus
Insmed (NASDAQ:INSM) Given New $269.00 Price Target at TD Cowen - MarketBeat
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks - AOL.com
HighVista Strategies LLC Reduces Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Acquired by Nebula Research & Development LLC - MarketBeat
Qube Research & Technologies Ltd Buys New Position in Insmed, Inc. $INSM - MarketBeat
TD Cowen raises Insmed stock price target to $269 on strong Brinsupri launch - Investing.com Canada
WINTON GROUP Ltd Purchases New Shares in Insmed, Inc. $INSM - MarketBeat
Stempoint Capital LP Sells 25,481 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed (Nasdaq: INSM) highlights TPIP, brensocatib data in ERS 2025 ALERT session - Stock Titan
Resolute Capital Asset Partners LLC Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Hsbc Holdings PLC Has $1.30 Million Stake in Insmed, Inc. $INSM - MarketBeat
B Group Inc. Sells 107,500 Shares of Insmed, Inc. $INSM - MarketBeat
Hood River Capital Management LLC Reduces Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Holdings Decreased by Kennedy Capital Management LLC - MarketBeat
Insmed, Inc. $INSM Shares Sold by Invesco Ltd. - MarketBeat
Jump Financial LLC Takes Position in Insmed, Inc. $INSM - MarketBeat
Bollard Group LLC Acquires New Holdings in Insmed, Inc. $INSM - MarketBeat
Marshall Wace LLP Acquires 417,124 Shares of Insmed, Inc. $INSM - MarketBeat
Quantbot Technologies LP Invests $2.22 Million in Insmed, Inc. $INSM - MarketBeat
Insmed (NASDAQ:INSM) Upgraded to "Strong-Buy" at Rothschild Redb - MarketBeat
Affinity Asset Advisors LLC Increases Holdings in Insmed, Inc. $INSM - MarketBeat
Dir Sharoky Files To Sell 20,000 Of Insmed Inc [INSM] - TradingView
Is Insmed Stock Built to Withstand a Pullback? - Trefis
Insmed Insider Sold Shares Worth $2,199,915, According to a Recent SEC Filing - marketscreener.com
INSMED Chair and CEO William Lewis Sells Over 10,000 Shares - TradingView
Schroder Investment Management Group Reduces Position in Insmed, Inc. $INSM - MarketBeat
Diametric Capital LP Purchases Shares of 7,757 Insmed, Inc. $INSM - MarketBeat
Will Insmed Incorporated (IM8N) stock outperform small cap peersJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
How Insmed Incorporated (IM8N) stock compares with tech leadersMarket Trend Review & Safe Capital Preservation Plans - Newser
Will Insmed Incorporated stock see PE expansionJuly 2025 Highlights & Reliable Breakout Forecasts - Newser
Insmed reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Rothschild & Co Redburn Initiates Coverage on Insmed With Buy Rating, $263 Price Target - marketscreener.com
Panagora Asset Management Inc. Sells 157,126 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Rothschild Redburn initiates Insmed stock with Buy rating, $263 target By Investing.com - Investing.com Canada
How Insmed Incorporated (IM8N) stock responds to job market shiftsOptions Play & Expert-Curated Trade Recommendations - Newser
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.55%
자본화:
|
볼륨(24시간):